60 DEGREES PHARMACEUTICALS, INC. (SXTP) Return on equity 2023–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-212.7%FY2025 · since FY2023: -77.3% → -212.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -212.7% | -15.7 pp |
| FY2024 | -196.9% | -119.6 pp |
| FY2023 | -77.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SXTP financial trends
SXTP RevenueSXTP Net incomeSXTP Net marginSXTP Gross profitSXTP Gross marginSXTP Operating incomeSXTP Operating marginSXTP Operating cash flowSXTP Free cash flowSXTP Capital expendituresSXTP Stock buybacksSXTP Dividends paidSXTP Total assetsSXTP Total liabilitiesSXTP Shareholders’ equitySXTP overview →